Entry
Name
Choline metabolism in cancer - Rousettus aegyptiacus (Egyptian rousette)
Description
Abnormal choline metabolism is emerging as a metabolic hallmark that is associated with oncogenesis and tumour progression. Following transformation, oncogenic signalling via pathways such as the RAS and PI3K-AKT pathways, and transcription factors associated with oncogenesis such as hypoxia-inducible factor 1 (HIF1) mediate overexpression and activation of choline cycle enzymes, which causes increased levels of choline-containing precursors and breakdown products of membrane phospholipids. These products of choline phospholipid metabolism, such as phosphocholine (PCho), diacylglycerol (DAG) and phosphatidic acid, may function as second messengers that are essential for the mitogenic activity of growth factors, particularly in the activation of the ras-raf-1-MAPK cascade and protein kinase C pathway.
Class
Human Diseases; Cancer: overview
BRITE hierarchy
Pathway map
Ortholog table
Organism
Rousettus aegyptiacus (Egyptian rousette) [GN:
ray ]
Gene
107497394 PDGFA; platelet-derived growth factor subunit A isoform X1 [KO:K04359 ]
107502078 PDGFB; platelet-derived growth factor subunit B isoform X1 [KO:K17386 ]
107504584 RALGDS; ral guanine nucleotide dissociation stimulator isoform X1 [KO:K08732 ]
107520152 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
107517828 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922 ] [EC:2.7.1.153 ]
107513958 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
107521668 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X1 [KO:K02649 ]
107517899 PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649 ]
107498704 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649 ]
107515968 EIF4EBP1; eukaryotic translation initiation factor 4E-binding protein 1 [KO:K07205 ]
107520114 PIP5K1C; LOW QUALITY PROTEIN: phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [KO:K00889 ] [EC:2.7.1.68 ]
107515925 RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392 ]
107519372 WASF1; wiskott-Aldrich syndrome protein family member 1 isoform X1 [KO:K05753 ]
107503537 WASF2; wiskott-Aldrich syndrome protein family member 2 [KO:K05748 ]
107498593 WASF3; LOW QUALITY PROTEIN: wiskott-Aldrich syndrome protein family member 3 [KO:K06083 ]
107516396 SLC44A1; choline transporter-like protein 1 isoform X1 [KO:K06515 ]
107515087 SLC44A2; choline transporter-like protein 2 isoform X1 [KO:K15377 ]
107508883 SLC44A3; choline transporter-like protein 3 isoform X1 [KO:K15282 ]
107514734 SLC22A1; solute carrier family 22 member 1 isoform X1 [KO:K08198 ]
107497040 SLC22A5; solute carrier family 22 member 5 isoform X1 [KO:K08202 ]
107497041 LOW QUALITY PROTEIN: solute carrier family 22 member 4-like [KO:K08202 ]
107506741 PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116 ] [EC:3.1.4.11 ]
Compound
C00093 sn-Glycerol 3-phosphate
C00670 sn-Glycero-3-phosphocholine
C04230 1-Acyl-sn-glycero-3-phosphocholine
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference
Authors
Glunde K, Bhujwalla ZM, Ronen SM
Title
Choline metabolism in malignant transformation.
Journal
Reference
Authors
Beloueche-Babari M, Chung YL, Al-Saffar NM, Falck-Miniotis M, Leach MO
Title
Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy.
Journal
Reference
Authors
Abalsamo L, Spadaro F, Bozzuto G, Paris L, Cecchetti S, Lugini L, Iorio E, Molinari A, Ramoni C, Podo F
Title
Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.
Journal
Reference
Authors
Foster DA
Title
Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.
Journal
Reference
Authors
Beloueche-Babari M, Jackson LE, Al-Saffar NM, Eccles SA, Raynaud FI, Workman P, Leach MO, Ronen SM
Title
Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells.
Journal
Reference
Authors
Ridgway ND
Title
The role of phosphatidylcholine and choline metabolites to cell proliferation and survival.
Journal
Reference
Authors
Awwad HM, Geisel J, Obeid R
Title
The role of choline in prostate cancer.
Journal
Reference
Authors
Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D'Ascenzo S, Millimaggi D, Pavan A, Dolo V, Canevari S, Podo F
Title
Alterations of choline phospholipid metabolism in ovarian tumor progression.
Journal
Reference
Authors
Ackerstaff E, Glunde K, Bhujwalla ZM
Title
Choline phospholipid metabolism: a target in cancer cells?
Journal
Reference
Authors
Park JB, Lee CS, Jang JH, Ghim J, Kim YJ, You S, Hwang D, Suh PG, Ryu SH
Title
Phospholipase signalling networks in cancer.
Journal
Reference
Authors
Yalcin A, Clem B, Makoni S, Clem A, Nelson K, Thornburg J, Siow D, Lane AN, Brock SE, Goswami U, Eaton JW, Telang S, Chesney J
Title
Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling.
Journal
Reference
Authors
Glunde K, Jiang L, Moestue SA, Gribbestad IS
Title
MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.
Journal
Reference
Authors
Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL, Armstrong MD, Arteaga CL, Lindsley CW, Brown HA
Title
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.
Journal
Reference
Authors
Foster DA, Xu L
Title
Phospholipase D in cell proliferation and cancer.
Journal
Mol Cancer Res 1:789-800 (2003)
Reference
Authors
Zhou H, Huang S
Title
mTOR signaling in cancer cell motility and tumor metastasis.
Journal
Related pathway
ray04810 Regulation of actin cytoskeleton
KO pathway
LinkDB
All DBs